Biogen Inc.
BIIBFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
9,676
Cost of Revenue
2,310
Gross Profit
7,366
Gross Margin
76.1%
Operating Income
2,490
Operating Margin
25.7%
Net Income
1,632
Net Margin
16.9%
EPS (Basic)
$11.20
EPS (Diluted)
$11.19
EBITDA
2,996
EBITDA Margin
31.0%
2023
12/31/2023
Revenue
9,836
Cost of Revenue
2,533
Gross Profit
7,302
Gross Margin
74.2%
Operating Income
2,097
Operating Margin
21.3%
Net Income
1,161
Net Margin
11.8%
EPS (Basic)
$8.02
EPS (Diluted)
$7.97
EBITDA
2,377
EBITDA Margin
24.2%
2022
12/31/2022
Revenue
10,173
Cost of Revenue
2,278
Gross Profit
7,895
Gross Margin
77.6%
Operating Income
2,889
Operating Margin
28.4%
Net Income
3,047
Net Margin
29.9%
EPS (Basic)
$20.97
EPS (Diluted)
$20.87
EBITDA
3,537
EBITDA Margin
34.8%
2021
12/31/2021
Revenue
10,982
Cost of Revenue
2,110
Gross Profit
8,872
Gross Margin
80.8%
Operating Income
2,791
Operating Margin
25.4%
Net Income
1,556
Net Margin
14.2%
EPS (Basic)
$10.44
EPS (Diluted)
$10.40
EBITDA
3,923
EBITDA Margin
35.7%
2020
12/31/2020
Revenue
13,445
Cost of Revenue
1,805
Gross Profit
11,639
Gross Margin
86.6%
Operating Income
4,593
Operating Margin
34.2%
Net Income
4,001
Net Margin
29.8%
EPS (Basic)
$24.86
EPS (Diluted)
$24.80
EBITDA
5,108
EBITDA Margin
38.0%